Niki BioSolutions, Inc. Additional Paid in Capital
Niki BioSolutions, Inc. (NIKI) had Additional Paid in Capital of $93.02 million as of 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2024-04-30
- 2023-12-31: Additional Paid in Capital $93.02M.
- 2023-06-30: Additional Paid in Capital $92.64M.
- 2022-12-31: Additional Paid in Capital $45.31M.
- 2022-06-30: Additional Paid in Capital $44.34M.
| Period end | Additional Paid in Capital |
|---|---|
| 2023-12-31 | $93.02M 20-F · filed 2024-04-30 |
| 2023-06-30 | $92.64M 6-K · filed 2023-12-22 |
| 2022-12-31 | $45.31M 20-F · filed 2024-04-30 |
| 2022-06-30 | $44.34M 6-K · filed 2022-09-30 |
| 2021-12-31 | $43.51M 20-F · filed 2023-04-28 |
| 2021-06-30 | $42.44M 6-K · filed 2021-09-15 |
| 2020-12-31 | $38.25M 20-F/A · filed 2023-01-17 |
| 2020-06-30 | $33.18M 6-K · filed 2020-09-02 |
| 2019-12-31 | $24.89M 20-F · filed 2021-04-19 |
| 2018-12-31 | $23.00M 20-F · filed 2020-04-29 |
| 2017-12-31 | $5.29M 20-F · filed 2019-04-15 |